65 related articles for article (PubMed ID: 38669000)
1. Advances in the treatment of Adamantinomatous craniopharyngioma: How to balance tumor control and quality of life in the current environment: a narrative review.
Chen A; Ai M; Sun T
Front Oncol; 2023; 13():1326595. PubMed ID: 38188294
[TBL] [Abstract][Full Text] [Related]
2. Comparison of central diabetes insipidus (antidiuretic hormone deficiency) and stalk effect in patients with adamantinomatous and papillary craniopharyngioma.
Feng Y; Zhong L
Acta Neurol Belg; 2024 Apr; ():. PubMed ID: 38669000
[TBL] [Abstract][Full Text] [Related]
3. Comparison of neuroendocrine dysfunction in patients with adamantinomatous and papillary craniopharyngiomas.
Feng Y; Ni M; Wang YG; Zhong LY
Exp Ther Med; 2019 Jan; 17(1):51-56. PubMed ID: 30651764
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and operative technique of transinfundibular craniopharyngioma.
Tang B; Xie S; Huang G; Wang Z; Yang L; Yang X; Xu S; Zeng E; Hong T
J Neurosurg; 2019 Jun; 133(1):119-128. PubMed ID: 31200374
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Endocrine and Metabolic Comorbidities in a National Cohort of Patients with Craniopharyngioma.
Jazbinšek S; Kolenc D; Bošnjak R; Faganel Kotnik B; Zadravec Zaletel L; Jenko Bizjan B; Vipotnik Vesnaver T; Battelino T; Janež A; Jensterle M; Kotnik P
Horm Res Paediatr; 2020; 93(1):46-57. PubMed ID: 32460296
[TBL] [Abstract][Full Text] [Related]
6. Association of histological subtype with risk of recurrence in craniopharyngioma patients: a systematic review and meta-analysis.
Wu J; Wu X; Yang YQ; Ding H; Yang L; Bao YY; Zhou L; Yang CX; Hong T
Neurosurg Rev; 2022 Feb; 45(1):139-150. PubMed ID: 34159471
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma.
Guo Y; Pei L; Li Y; Li C; Gui S; Ni M; Liu P; Zhang Y; Zhong L
Front Endocrinol (Lausanne); 2023; 14():1180591. PubMed ID: 37324266
[TBL] [Abstract][Full Text] [Related]
8. The molecular pathogenesis of craniopharyngiomas.
Campanini ML; Almeida JP; Martins CS; de Castro M
Arch Endocrinol Metab; 2023 Mar; 67(2):266-275. PubMed ID: 36748936
[TBL] [Abstract][Full Text] [Related]
9. New developments and concepts in the diagnosis and management of diabetes insipidus (AVP-deficiency and resistance).
Angelousi A; Alexandraki KI; Mytareli C; Grossman AB; Kaltsas G
J Neuroendocrinol; 2023 Jan; 35(1):e13233. PubMed ID: 36683321
[TBL] [Abstract][Full Text] [Related]
10. Contemporary Biological Insights and Clinical Management of Craniopharyngioma.
Apps JR; Muller HL; Hankinson TC; Yock TI; Martinez-Barbera JP
Endocr Rev; 2023 May; 44(3):518-538. PubMed ID: 36574377
[TBL] [Abstract][Full Text] [Related]
11. Effect of preserving the pituitary stalk during resection of craniopharyngioma: A case series.
Huang K; Zhou L; Chen Y; Liu C; Zhao L; Liu Y; Liu P
Asian J Surg; 2023 Apr; 46(4):1639-1640. PubMed ID: 36207206
[No Abstract] [Full Text] [Related]
12. Craniopharyngiomas: Surgery and Radiotherapy.
Gorelyshev S; Savateev AN; Mazerkina N; Medvedeva O; Konovalov AN
Adv Tech Stand Neurosurg; 2022; 45():97-137. PubMed ID: 35976448
[TBL] [Abstract][Full Text] [Related]
13. Clinical Features of Craniopharyngioma With Tumoral Hemorrhage: A Retrospective Case-Controlled Study.
Chen Y; Hu F; Wang J; Huang K; Liu W; Tan Y; Zhao K; Xiao Q; Lei T; Shu K
Front Surg; 2022; 9():845273. PubMed ID: 35360427
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
